171 related articles for article (PubMed ID: 34971706)
1. The protease SENP2 controls hepatic gluconeogenesis by regulating the SUMOylation of the fuel sensor AMPKα.
Dou X; Zhou WY; Ding M; Ma YJ; Yang QQ; Qian SW; Tang Y; Tang QQ; Liu Y
J Biol Chem; 2022 Feb; 298(2):101544. PubMed ID: 34971706
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SENP2-mediated Akt deSUMOylation promotes cardiac regeneration via activating Akt pathway.
Chen Y; Xu T; Li M; Li C; Ma Y; Chen G; Sun Y; Zheng H; Wu G; Liao W; Liao Y; Chen Y; Bin J
Clin Sci (Lond); 2021 Mar; 135(6):811-828. PubMed ID: 33687053
[TBL] [Abstract][Full Text] [Related]
4. Hepatic p38α regulates gluconeogenesis by suppressing AMPK.
Jing Y; Liu W; Cao H; Zhang D; Yao X; Zhang S; Xia H; Li D; Wang YC; Yan J; Hui L; Ying H
J Hepatol; 2015 Jun; 62(6):1319-27. PubMed ID: 25595884
[TBL] [Abstract][Full Text] [Related]
5. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
Liu Y; Deng J; Fan D
Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294
[TBL] [Abstract][Full Text] [Related]
7. Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.
Kim EY; Chen L; Ma Y; Yu W; Chang J; Moskowitz IP; Wang J
J Mol Cell Cardiol; 2012 Mar; 52(3):638-49. PubMed ID: 22155005
[TBL] [Abstract][Full Text] [Related]
8. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
[TBL] [Abstract][Full Text] [Related]
9. The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels.
Chen X; Zhang Y; Ren X; Su Q; Liu Y; Dang X; Qin Y; Yang X; Xing Z; Shen Y; Wang Y; Bai Z; Yeh ETH; Wu H; Qi Y
J Biol Chem; 2021 Oct; 297(4):101183. PubMed ID: 34509475
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
12. Control of adipogenesis by the SUMO-specific protease SENP2.
Chung SS; Ahn BY; Kim M; Choi HH; Park HS; Kang S; Park SG; Kim YB; Cho YM; Lee HK; Chung CH; Park KS
Mol Cell Biol; 2010 May; 30(9):2135-46. PubMed ID: 20194620
[TBL] [Abstract][Full Text] [Related]
13. The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.
Wang H; You G
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1293-1301. PubMed ID: 31054272
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of basal and glucagon-induced hepatic glucose production by 991 and other pharmacological AMPK activators.
Johanns M; Corbet C; Jacobs R; Drappier M; Bommer GT; Herinckx G; Vertommen D; Tajeddine N; Young D; Messens J; Feron O; Steinberg GR; Hue L; Rider MH
Biochem J; 2022 Jun; 479(12):1317-1336. PubMed ID: 35670459
[TBL] [Abstract][Full Text] [Related]
15. L-Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice.
Wang Y; Guan Y; Xue L; Liu J; Yang Z; Nie C; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Li Y; Wang L
Food Funct; 2021 Mar; 12(4):1745-1756. PubMed ID: 33502423
[TBL] [Abstract][Full Text] [Related]
16. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.
Xiao N; Li H; Yu W; Gu C; Fang H; Peng Y; Mao H; Fang Y; Ni W; Yao M
FASEB J; 2019 Jan; 33(1):163-174. PubMed ID: 29969578
[TBL] [Abstract][Full Text] [Related]
17. SUMO-specific protease 2 mediates leptin-induced fatty acid oxidation in skeletal muscle.
Koo YD; Lee JS; Lee SA; Quaresma PGF; Bhat R; Haynes WG; Park YJ; Kim YB; Chung SS; Park KS
Metabolism; 2019 Jun; 95():27-35. PubMed ID: 30902749
[TBL] [Abstract][Full Text] [Related]
18. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
19. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
